首页> 外文期刊>Alimentary pharmacology & therapeutics. >Letter: Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome in China
【24h】

Letter: Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome in China

机译:信件:经颈静脉肝内门体分流术治疗中国布加综合征

获取原文
获取原文并翻译 | 示例
           

摘要

Sirs, A single-centre retrospective study by Tripathi et al. further confirmed an excellent outcome of transjugular intrahepatic portosystemic shunt (TIPSS) for the treatment of Budd-Chiari syndrome (BCS). Notably, the cases enrolled into this study appeared to be a subgroup of data from a European multi-centre study, and an extended group of data from a previous study by the same study team. Thus, the conclusions of this study were very similar to those of previous studies, such as shunt patency and survival.
机译:主席先生,Tripathi等人的单中心回顾性研究。进一步证实经颈静脉肝内门体系统分流术(TIPSS)治疗Budd-Chiari综合征(BCS)的出色结果。值得注意的是,参与本研究的病例似乎是来自欧洲多中心研究的数据子集,是同一研究团队先前研究的扩展数据集。因此,该研究的结论与以前的研究非常相似,例如分流通畅性和生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号